Table 5.
Psychiatric medications at admission and discharge, and change in psychiatric medications in 56 patients
| Measure | Number of subjects (%) | ||
|---|---|---|---|
| a. Psychiatric medications on admission a | |||
| None | 6 (11%) | ||
| Antidepressants (TCAs, SSRIs, SNRIs, buproprion) | 40 (71%) | ||
| Benzodiazepines | 22 (39%) | ||
| Antipsychotics | 23 (41%) | ||
| Mood stabilizers and anticonvulsants (e.g., lithium, valproic acid, gabapentin) |
20 (36%) | ||
| Other (e.g., adderall, campral, methadone, trazodone) | 17 (30%) | ||
| b. Psychiatric medications on discharge a | |||
| None | 3 (5%) | ||
| Antidepressants | 43 (77%) | ||
| Benzodiazepines | 26 (46%) | ||
| Antipsychotics | 35 (62%) | ||
| Mood stabilizers and anticonvulsants | 23 (41%) | ||
| Other | 26 (46%) | ||
| c. Change in psychiatric medications | No changeb | Added | Removed |
| Antidepressants | 51 (91%) | 4 (7%) | 1 (2%) |
| Benzodiazepines | 42 (75%) | 9 (16%) | 5 (9%) |
| Antipsychotics | 40 (71%) | 14 (25%) | 2 (4%) |
| Mood stabilizers and anticonvulsants | 49 (88%) | 5 (9%) | 2 (4%) |
Notes. SNRIs, serotonin and norepinephrine reuptake inhibitors (e.g., venlafaxine, duloxetine); SSRIs, selective serotonin reuptake inhibitors (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram); TCAs, tricyclic antidepressants (e.g., clomipramine).
a
The sum of the percentages exceeds 100% because polypharmacy was common.
b
The No Change category includes both those who were not taking the indicated class of medication at admission nor taking it at discharge, and those were were taking the indicated class medication at admission and continued to take it at discharge.